Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.80%
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.00
Flat results in Sep 26
Stock is technically in a Bearish range
With ROE of 6.3, it has a Very Expensive valuation with a 1.2 Price to Book Value
Below par performance in long term as well as near term
Stock DNA
Trading & Distributors
INR 72 Cr (Micro Cap)
20.00
40
0.00%
-0.09
6.25%
1.24
Total Returns (Price + Dividend) 
Fervent Synerg. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Fervent Synergies Ltd is Rated Strong Sell
Fervent Synergies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Oct 2025, reflecting a shift from a previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company's performance and outlook.
Read More
Fervent Synergies Ltd is Rated Strong Sell
Fervent Synergies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Oct 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 21 October 2026, providing investors with the latest insights into its performance and valuation.
Read More
Fervent Synergies Ltd is Rated Strong Sell
Fervent Synergies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Oct 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 10 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read More Announcements 
Board Meeting Outcome for Outcome Of Board Meeting
29-Oct-2026 | Source : BSEas attached
Unaudited Results For The Quarter Ended 30.9.26
29-Oct-2026 | Source : BSEas attached
Board Meeting Intimation for Unaudited Financials For The Quarter Ended 30.9.26
16-Oct-2026 | Source : BSEFervent Synergies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 inter alia to consider and approve as attached
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Vijay Thakkar (62.3%)
Blue Berry Securities Pvt Ltd (4.95%)
8.34%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 0.00% vs -85.77% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 100.00% vs -77.01% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 87.67% vs 15.87% in Sep 2024
Growth in half year ended Sep 2025 is 645.45% vs -42.11% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -58.80% vs 186.05% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 20.33% vs 339.29% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -49.63% vs 33.53% in Mar 2025
YoY Growth in year ended Mar 2026 is 29.49% vs 122.98% in Mar 2025